dsm-firmenich Animal Nutrition & Health in the news

dsm-firmenich opened a new advanced feed additive plant in India to locally produce Mycofix® solutions, boosting efficiency and supporting animal health in the Asia-Pacific region.

dsm-firmenich is divesting its Animal Nutrition & Health business to CVC Capital Partners for about €2.2 billion, while retaining a 20% stake, to focus on its consumer businesses.

DSM-Firmenich is divesting its Animal Nutrition & Health business to CVC Capital Partners for €2.2 billion, retaining a 20% stake, as a final step to focus on consumer nutrition, health, and beauty.

DSM-Firmenich is selling its Animal Nutrition & Health division for €2.2 billion to CVC Capital Partners to streamline its portfolio and reduce exposure to volatile feed input markets.

CVC Capital Partners acquired Animal Nutrition & Health from dsm-firmenich for ‡2.2 billion, with White & Case advising on the carve-out transaction.

dsm-firmenich is divesting its Animal Nutrition & Health business to CVC for €2.2 billion, retaining a 20% stake, to become a focused consumer health company.

DSM-Firmenich is divesting its Animal Nutrition & Health business, splitting it into two new companies, while also announcing a share repurchase program and a new dividend policy.

Schothorst Feed Research will use dsm-firmenich's Sustell platform to enhance sustainability assessments and solutions in animal feed production.

Precision glycans improve gut health and sustainability in animal production by enhancing feed efficiency and reducing emissions.

dsm-firmenich ANH partners with Milk Sustainability Center to integrate sustainability data tools for dairy farmers, while preparing to sell its ANH business.

dsm-firmenich ANH opened a new state-of-the-art feed additive plant in India focusing on mycotoxin risk management to support growth in Asia Pacific.

Animal Nutrition & Health successfully managed its separation from DSM-Firmenich, reducing turnover through effective change management and employee engagement.

dsm-firmenich posted strong H1 2025 growth, advanced its strategic plan including divesting Feed Enzymes and exiting Animal Nutrition & Health, and expects €2.4 billion adjusted EBITDA for 2025.

Nutreco is exploring acquiring DSM-Firmenich's animal nutrition division to strengthen its market position, facing competition and regulatory challenges.

Dsm-firmenich is nearing the sale of its animal nutrition business to private equity and industry bidders, aiming to finalize the deal this summer as part of a strategic focus shift.

A global survey by dsm-firmenich found high levels of harmful mycotoxins in animal feeds, especially in China and South Asia, underscoring risks to animal health and the need for better management.

dsm-firmenich and Zenkei collaborate to enhance sustainability in Japan's egg and feed industry using the Sustell platform and eco-friendly feed solutions.

2024 analyses reveal increased mycotoxin contamination worldwide, posing significant risks to animal feed quality and requiring robust management strategies.

dsm-firmenich sold its Feed Enzymes Alliance stake to Novonesis for 1.5 billion euros, maintaining a commercial partnership in animal nutrition.

DSM-Firmenich sold its Feed Enzymes Alliance stake to Novonesis for 1.5 billion euros and plans to spin off its Animal Nutrition & Health business by 2025.